Plandai Biotechnology, Inc. New Products to Hit the Market With Higher Absorption Rate
(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 05/14/13 -- In a series of articles, Stock House Group, a research and content development investment relations firm, will lay out Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) three new products all being individually labeled and branded under the Phytofare™ name. In addition to the products, the patented extraction process the company will use to bring customers its healthy lineup of extracts will also be highlighted. This installment will focus on the first of the three, highly bioavailable extracts -- Phytofare™ Catechin Extract.
Phytofare™ Catechin Extract ("PCE") is a natural flavonoid rich in phenols and antioxidants. Catechins are chemical compounds essential to boosting the immune system, lowering cholesterol, fighting obesity, and aiding in the prevention of cancers, malaria, and many other parasitic and viral infections.
Phytofare™ PCE is a 65 percent polyphenol extract containing 85-88 percent catechins through the release of the active and stable immature catechin precursors from the green tea leaf. Phytonutrients, particularly catechins derived from green tea and its components, have been thoroughly researched (over 200 published scientific papers) and shown to have anti-viral and anti-inflammatory properties.
Most green tea extracts are made from dried unfermented tea leaf -- meaning that the antioxidants have been compromised in stability and activity. However, Phytofare™ PCE is recovered from live plant material, retaining the catechins in an active and stable form.
Plandaí Biotechnology will bring to the market a scientifically improved, more bioavailable line of products. To accomplish this, Plandaí will put on its lab coats and employ a patented extraction process that allows this biotech to beat its competition. This process begins with the first product the company will bring to market, Phytofare™ Catechin Extract.
Continue reading this article at .
About Stock House Group
Stock House Group is a full service Investment Relations firm specializing in Awareness, Research, and Content Development. The firm offers a platform that allows CEOs to tell their story through the press with Feature Articles, Research Reports, and CEO Interviews. At the same time, Stock House Group is building a library of Research for Investors to use that allows them to get more informed on small cap stocks. For more information visit Stock House Group at .
Contact:
Stock House Group
646-397-4020
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.05.2013 - 06:30 Uhr
Sprache: Deutsch
News-ID 1226940
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Equipment & Supplies
Anmerkungen:
Diese Pressemitteilung wurde bisher 260 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Plandai Biotechnology, Inc. New Products to Hit the Market With Higher Absorption Rate
"
steht unter der journalistisch-redaktionellen Verantwortung von
Plandai Biotechnology, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
